Ioxilan

Ioxilan is a diagnostic contrast agent.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Ioxilan is a diagnostic contrast agent.[1] It is injected intravenously before taking X-ray images to increase arterial contrast in the final image. It was marketed in the US under the trade name Oxilan by Guerbet, L.L.C., but was discontinued in 2017.[2]

Mechanism of action

edit edit source

Ioxilan is an iodinated contrast agent.[2]

References

edit edit source
  1. ^ Cheng KT (December 2007). "Ioxilan carbonate particles". Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US). PMID 20641969. Wikipedia revision 1365020062, retrieved 2026-11-18
  2. ^ a b Oxilan FDA Professional Drug Information. Accessed 2021-04-07. Wikipedia revision 1365020062, retrieved 2026-11-18
Contrast media (V08)X-ray and CT Iodinated,
Water insoluble Non-iodinated MRI Ultrasound

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365020062 under CC BY-SA 4.0; modifications have been made.